QUALIGEN THERAPEUTICS
DEAD

Serial Number

90566145

Owner

QUALIGEN, INC.

Attorney

Paul E. Rauch

Filing Date

Mar 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

QUALIGEN THERAPEUTICS Trademark

Serial Number: 90566145

QUALIGEN THERAPEUTICS is a trademark filed by QUALIGEN, INC. on March 8, 2021. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

QUALIGEN, INC. (18 trademarks)

CARLSBAD, CA 92011

Entity Type: 03

Trademark Details

Filing Date

March 8, 2021

Registration Date

Not Registered

Published for Opposition

August 31, 2021

Goods & Services

Medical devices for use in treating or diagnosing viral infections; Medical devices for use in treating or diagnosing cancer

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 28, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 28, 2022 ABN6
CORRECTED NOA E-MAILED
Jul 21, 2022 NOAC
DIVISIONAL PROCESSING COMPLETE
Jul 20, 2022 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 18, 2022 AITU
DIVISIONAL REQUEST RECEIVED
Jun 22, 2022 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 22, 2022 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2022 EXRA
SOU EXTENSION 1 GRANTED
Apr 25, 2022 EX1G
SOU EXTENSION 1 FILED
Apr 25, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 25, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 26, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 31, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 31, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 11, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 23, 2021 CNEA
ASSIGNED TO EXAMINER
Jul 22, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 8, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2021 NWOS
NEW APPLICATION ENTERED
Mar 11, 2021 NWAP